查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945227

2026年全球胃癌診斷市場報告

Gastric Cancer Diagnostic Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，胃癌診斷市場成長顯著，預計到2025年將達到27.8億美元，到2026年將達到29.8億美元，複合年成長率為7.2%。過去幾年的成長可歸因於多種因素，例如螢光探針供應有限、依賴傳統的單色FISH技術、基因研究的不斷深入、醫院和檢查室基礎設施的改善以及基礎細胞遺傳學診斷方法的普及。

預計未來幾年胃癌診斷市場將維持強勁成長，2030年市場規模將達到38.7億美元，複合年成長率（CAGR）為6.8%。預測期內的成長要素包括多重和高通量探針的開發、精準醫療需求的成長、基因和藥物研究的拓展、影像和定量技術的進步，以及監管合規性和品質標準的加強。預測期內的主要趨勢包括多重和高通量FISH探針的日益普及、基因和分子診斷應用的擴展、在臨床和藥物研究中的日益廣泛應用、與先進成像和分析技術的融合，以及對探針準確性和靈敏度的日益重視。

胃癌發生率的上升預計將推動胃癌診斷市場的成長。胃癌是胃黏膜的惡性腫瘤，其特徵是細胞不受控制地增殖，並可侵襲或轉移至周圍組織。病例增加的主要原因是不健康的飲食習慣，例如過量食用鹽漬、燻製和加工食品，這些食品會損害胃黏膜並增加癌症風險。胃癌診斷技術能夠早期發現惡性病變，有助於儘早實施適當的治療並改善患者預後。提供快速且準確的結果可提高臨床效率並支持更好的疾病管理。例如，根據美國癌症協會2024年5月發布的報告，美國新增胃癌病例數預計將增加至26,890例（高於2023年的26,500例），顯示對有效診斷解決方案的需求日益成長。

該市場中的企業正致力於利用人工智慧驅動的內視鏡診斷工具進行創新，以實現更早的檢測和更高的準確率。以人工智慧為基礎的內視鏡診斷輔助設備可在內視鏡檢查過程中即時分析影片影像，以偵測消化器官系統異常情況，包括早期癌症。 2024年3月，日本醫療技術公司AI Medical Services Co., Ltd.發布了「GastroAI-model G」。該系統利用深度學習技術，在內視鏡螢幕上突出顯示可疑病變，即時提醒醫生並提示進行進一步檢查或切片檢查。這項創新技術提高了診斷準確率，並實現了早期干預，這對改善患者預後至關重要。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球胃癌診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 多重高通量FISH探針的應用日益廣泛
    • 不斷擴展的基因和分子診斷應用
    • 在臨床和藥物研究中的應用日益廣泛
    • 與先進成像和分析技術的整合
    • 更加重視探頭的精度和靈敏度

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 研究所
  • 製藥公司
  • 生技公司
  • 學術和遺傳研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球胃癌診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球胃癌診斷市場規模、比較及成長率分析
  • 全球胃癌診斷市場表現：規模與成長，2020-2025年
  • 全球胃癌診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過診斷方法
  • 內視鏡檢查、影像診斷、切片檢查、臨床檢測、生物標記檢測
  • 依產品
  • 試劑、耗材和設備
  • 透過技術
  • 分子診斷、免疫檢測、次世代定序和其他技術
  • 透過使用
  • 早期診斷、篩檢和監測
  • 最終用戶
  • 醫院、診所、診斷檢查室和其他最終用戶
  • 按類型細分：內視鏡
  • 傳統內視鏡、染色內視鏡、窄頻成像、共聚焦雷射內視鏡顯微鏡、膠囊內視鏡
  • 按類型細分：診斷成像
  • 電腦斷層掃描、磁振造影、正子斷層掃描和超音波
  • 按類型細分：切片檢查
  • 鉗取切片檢查、針取切片、超音波引導下切片檢查、腹腔鏡切片檢查
  • 按類型細分：檢查
  • 血液檢查、糞便檢驗、尿素呼吸檢測、血清學檢查
  • 按類型細分：基於生物標記的檢測
  • 基因檢測、蛋白質生物標記檢測、循環腫瘤DNA檢測、微型RNA檢測

第10章 區域與國家分析

  • 全球胃癌診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球胃癌診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 胃癌診斷市場：競爭格局及市場佔有率（2024年）
  • 胃癌診斷市場：公司估值矩陣
  • 胃癌診斷市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Quest Diagnostics Incorporated

第37章：其他領先和創新企業

  • Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen NV, DiaSorin SpA, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年胃癌診斷市場：提供新機會的國家
  • 2030年胃癌診斷市場：新興細分市場機會
  • 2030年胃癌診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MGCDA03_G26Q1

Gastric cancer diagnostics encompass a range of tests and procedures designed to detect and confirm the presence of cancer in the stomach. Their primary objective is to identify gastric tumors at an early stage, determine tumor type and progression, and support effective treatment planning.

The primary types of gastric cancer diagnostics include endoscopy, imaging, biopsy, laboratory tests, and biomarker-based testing. Endoscopy involves inserting a flexible tube equipped with a camera and light to visually examine internal organs and tissues. The products used in these diagnostics include reagents, consumables, and instruments, while the technologies employed range from molecular diagnostics and immunoassays to next-generation sequencing and others. These diagnostics are applied for early detection, screening, and disease monitoring, catering to a wide range of end users such as hospitals, clinics, diagnostic laboratories, and other healthcare facilities.

Tariffs have influenced the FISH probe market by raising the cost of imported fluorescent dyes, probe reagents, and advanced manufacturing equipment. Segments such as multiplex and high-throughput probes are particularly affected, with Asia-Pacific regions including China and India experiencing significant import duties. This has led to higher production costs and potential delays in supply. Positively, tariffs are encouraging local manufacturing, innovation in probe synthesis, and investment in domestic production capabilities, enhancing long-term market resilience.

The gastric cancer diagnostic market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic market statistics, including gastric cancer diagnostic industry global market size, regional shares, competitors with a gastric cancer diagnostic market share, detailed gastric cancer diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic industry. This gastric cancer diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric cancer diagnostic market size has grown strongly in recent years. It will grow from $2.78 billion in 2025 to $2.98 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to limited availability of fluorescent probes, reliance on traditional single-color FISH methods, growing genetic research initiatives, increasing hospital and laboratory infrastructure, adoption of basic cytogenetic diagnostics.

The gastric cancer diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to development of multiplex and high-throughput probes, rising demand for precision medicine, expansion of genetic and pharmaceutical research, technological advancements in imaging and quantification, increasing regulatory compliance and quality standards. Major trends in the forecast period include rising adoption of multiplex and high-throughput fish probes, expansion of genetic and molecular diagnostic applications, growing use in clinical and pharmaceutical research, integration with advanced imaging and analysis technologies, increased focus on probe accuracy and sensitivity.

The rising incidence of gastric cancer is expected to drive growth in the gastric cancer diagnostic market. Gastric cancer, a malignant tumor of the stomach lining, develops when cells grow uncontrollably and can invade surrounding tissues or metastasize. The increase in cases is largely attributed to unhealthy dietary habits, including high consumption of salted, smoked, and processed foods, which damage the stomach lining and elevate cancer risk. Gastric cancer diagnostics facilitate early detection of malignant lesions, enabling timely treatment and improved patient outcomes. They enhance clinical efficiency by providing rapid and accurate results that support better disease management. For example, in May 2024, the American Cancer Society reported 26,890 new stomach cancer cases in the U.S., up from 26,500 in 2023, highlighting the growing need for effective diagnostic solutions.

Companies in this market are innovating with AI-powered endoscopic diagnostic tools to improve early detection and accuracy. AI-based endoscopic diagnostic support devices analyze video images in real time during endoscopy to detect gastrointestinal abnormalities, including early-stage cancer. In March 2024, AI Medical Service Inc., a Japan-based medical technology company, launched GastroAI-model G, which uses deep learning to highlight suspicious lesions on the endoscopic screen, alerting physicians instantly for further examination or biopsy. This innovation improves diagnostic accuracy and enables earlier intervention, which is critical for better patient outcomes.

In April 2025, SSI Diagnostica Group, a Denmark-based microbiology company, acquired Gulf Coast Scientific Corporation, a U.S.-based diagnostics firm specializing in H. pylori testing for gastric cancer risk detection. This acquisition strengthens SSI Diagnostica's gastrointestinal disease testing capabilities, enhances its presence in the U.S. diagnostics market, and supports growth through innovation and complementary technology in gastric cancer diagnostics.

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastric cancer diagnostic market consists of revenues earned by entities by providing services such as genetic counselling, risk assessment programmes, telepathology consultations, and patient navigation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric cancer diagnostics market also includes sales of liquid biopsy kits, rapid diagnostic test (RDT) devices, digital pathology scanners, contrast agents for imaging, and lab-on-a-chip systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gastric cancer diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Type: Endoscopy; Imaging; Biopsy; Laboratory Tests; Biomarker-Based Testing
  • 2) By Product: Reagents And Consumables; Instruments
  • 3) By Technology: Molecular Diagnostics; Immunoassays; Next-Generation Sequencing; Other Technologies
  • 4) By Application: Early Diagnosis; Screening; Monitoring
  • 5) By End User: Hospitals; Clinics; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Endoscopy: Conventional Endoscopy; Chromoendoscopy; Narrow Band Imaging; Confocal Laser Endomicroscopy; Capsule Endoscopy
  • 2) By Imaging: Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography; Ultrasound
  • 3) By Biopsy: Forceps Biopsy; Needle Biopsy; Endoscopic Ultrasound-Guided Biopsy; Laparoscopic Biopsy
  • 4) By Laboratory Tests: Blood Tests; Stool Tests; Urea Breath Test; Serology
  • 5) By Biomarker-Based Testing: Genetic Testing; Protein Biomarker Testing; Circulating Tumor DNA Testing; Microribonucleic Acid Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; Qiagen N.V.; DiaSorin S.p.A; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Foundation Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Fujirebio Inc.; MiRXES Pte Ltd.; BIOCEPT Inc.; Pillar Biosciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Gastric Cancer Diagnostic Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Gastric Cancer Diagnostic Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Gastric Cancer Diagnostic Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Gastric Cancer Diagnostic Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex And High-Throughput Fish Probes
    • 4.2.2 Expansion Of Genetic And Molecular Diagnostic Applications
    • 4.2.3 Growing Use In Clinical And Pharmaceutical Research
    • 4.2.4 Integration With Advanced Imaging And Analysis Technologies
    • 4.2.5 Increased Focus On Probe Accuracy And Sensitivity

5. Gastric Cancer Diagnostic Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Research Laboratories
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Academic And Genetic Research Institutions

6. Gastric Cancer Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastric Cancer Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Gastric Cancer Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Gastric Cancer Diagnostic Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Gastric Cancer Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Gastric Cancer Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastric Cancer Diagnostic Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastric Cancer Diagnostic Market Segmentation

  • 9.1. Global Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing
  • 9.2. Global Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Consumables, Instruments
  • 9.3. Global Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies
  • 9.4. Global Gastric Cancer Diagnostic Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Early Diagnosis, Screening, Monitoring
  • 9.5. Global Gastric Cancer Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Laboratories, Other End Users
  • 9.6. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy
  • 9.7. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound
  • 9.8. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy
  • 9.9. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Tests, Stool Tests, Urea Breath Test, Serology
  • 9.10. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biomarker-Based Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

10. Gastric Cancer Diagnostic Market Regional And Country Analysis

  • 10.1. Global Gastric Cancer Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Gastric Cancer Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastric Cancer Diagnostic Market

  • 11.1. Asia-Pacific Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastric Cancer Diagnostic Market

  • 12.1. China Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastric Cancer Diagnostic Market

  • 13.1. India Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastric Cancer Diagnostic Market

  • 14.1. Japan Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastric Cancer Diagnostic Market

  • 15.1. Australia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastric Cancer Diagnostic Market

  • 16.1. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastric Cancer Diagnostic Market

  • 17.1. South Korea Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastric Cancer Diagnostic Market

  • 18.1. Taiwan Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastric Cancer Diagnostic Market

  • 19.1. South East Asia Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastric Cancer Diagnostic Market

  • 20.1. Western Europe Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastric Cancer Diagnostic Market

  • 21.1. UK Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastric Cancer Diagnostic Market

  • 22.1. Germany Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastric Cancer Diagnostic Market

  • 23.1. France Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastric Cancer Diagnostic Market

  • 24.1. Italy Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastric Cancer Diagnostic Market

  • 25.1. Spain Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastric Cancer Diagnostic Market

  • 26.1. Eastern Europe Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastric Cancer Diagnostic Market

  • 27.1. Russia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastric Cancer Diagnostic Market

  • 28.1. North America Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastric Cancer Diagnostic Market

  • 29.1. USA Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastric Cancer Diagnostic Market

  • 30.1. Canada Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastric Cancer Diagnostic Market

  • 31.1. South America Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastric Cancer Diagnostic Market

  • 32.1. Brazil Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastric Cancer Diagnostic Market

  • 33.1. Middle East Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastric Cancer Diagnostic Market

  • 34.1. Africa Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastric Cancer Diagnostic Market Regulatory and Investment Landscape

36. Gastric Cancer Diagnostic Market Competitive Landscape And Company Profiles

  • 36.1. Gastric Cancer Diagnostic Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Gastric Cancer Diagnostic Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Gastric Cancer Diagnostic Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Gastric Cancer Diagnostic Market Other Major And Innovative Companies

  • Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

38. Global Gastric Cancer Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Market

40. Gastric Cancer Diagnostic Market High Potential Countries, Segments and Strategies

  • 40.1 Gastric Cancer Diagnostic Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Gastric Cancer Diagnostic Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Gastric Cancer Diagnostic Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer